 |
|
Lung cancer
While the anti-tumor effect of Avemar was not tested for lung cancer, a pilot study aimed at investigating it influence on quality of life was conducted on 16 patients (8 male, 8 female, 7 small cell lung cancer(SCLC) and 9 adanocarcinoma). The majority of patients were treated with chemo/radiotherapy. During a mean observation period of 8 ± 2 months a self-control test using an EORTC QLQ-C30 questionnaire was conducted. Following treatment with Avemar for 12 weeks, a significant improvement was achieved in the global state of health, social functions and fatigue, with a more modest non-significant positive trend in mood and apetite parameters. The effect on fatigue is of primary importance, although major conclusions, owing to the low number of patients tested, can not be drawn.
|
 |
|
 |
